Precision Biosensor

Precision Biosensor Equity

The The Equity of Precision Biosensor (335810.KQ) as of Oct 11, 2026 is 32.77 B KRW. In the previous year, The Equity was 25.70 B KRW — a change of 27.51% (higher).

Equity

32.77 BKRW

YoY

27.51%

Last updated:

In 2025, Precision Biosensor's equity was 32.77 B KRW, a 27.51% increase from the 25.70 B KRW equity in the previous year.

The Precision Biosensor Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
-1.52 B KRW
Jan 1, 2019
11.32 B KRW
Jan 1, 2020
37.22 B KRW
Jan 1, 2021
38.35 B KRW
Jan 1, 2022
33.38 B KRW
Jan 1, 2023
32.03 B KRW
Jan 1, 2024
25.70 B KRW
Jan 1, 2025
32.77 B KRW
The Precision Biosensor Equity history
YEAREquityYoY
32.77 BKRW+27.51%
25.70 BKRW-19.76%
32.03 BKRW-4.04%
33.38 BKRW-12.98%
38.35 BKRW+3.04%
37.22 BKRW+228.90%
11.32 BKRW-843.39%
-1.52 BKRW-159.79%
2.55 BKRW—
Access this data via the Eulerpool API
Get Free API Key

Precision Biosensor Stock analysis

What does Precision Biosensor do? Precision Biosensor is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Precision Biosensor's Equity

Precision Biosensor's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Precision Biosensor's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Precision Biosensor's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Precision Biosensor's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Precision Biosensor’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Precision Biosensor stock

The Equity of Precision Biosensor is 32.77 B KRW in 2025.

The Equity of Precision Biosensor changed from 25.70 B KRW to 32.77 B KRW, representing a 27.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Precision Biosensor since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Precision Biosensor historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Precision Biosensor

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Precision Biosensor